COVID-19 Immunisation

Infectious Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Moderna
ModernaCAMBRIDGE, MA
1 program
Patient letter and clinician communicationN/A1 trial
Active Trials
NCT06646406Completed114,165Est. Apr 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
ModernaPatient letter and clinician communication

Clinical Trials (1)

Total enrollment: 114,165 patients across 1 trials

NCT06646406ModernaPatient letter and clinician communication

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Start: Oct 2024Est. completion: Apr 2025114,165 patients
N/ACompleted

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space